Working… Menu

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02262338
Recruitment Status : Completed
First Posted : October 13, 2014
Last Update Posted : September 18, 2018
Information provided by (Responsible Party):
ArmaGen, Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 27, 2017
Actual Study Completion Date : March 27, 2017